Relay Therapeutics, Inc. (RLAY) Share-based Payment Arrangement, Expense USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Relay Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2024.
  • Relay Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $27.2 M, a 26.4% increase year-over-year.
  • Relay Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $91.7 M, a 42.8% increase year-over-year.
  • Relay Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $86 M, a 53.2% increase from 2022.
  • Relay Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $56.1 M, a 15.9% increase from 2021.
  • Relay Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $48.5 M, a 51.6% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $91.7 M $27.2 M +$5.67 M +26.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $86 M $19.3 M +$5.45 M +39.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $80.6 M $21.8 M +$8.12 M +59.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $72.5 M $23.4 M +$8.26 M +54.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $64.2 M $21.5 M +$8.06 M +59.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $56.1 M $13.8 M +$3.6 M +35.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $52.5 M $13.7 M +$1.3 M +10.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $51.2 M $15.1 M -$1 M -6.19% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $52.2 M $13.5 M +$3.78 M +39.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $48.5 M $10.2 M -$4.33 M -29.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $52.8 M $12.4 M +$489 K +4.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $52.3 M $16.1 M +$12.1 M +300% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $40.2 M $9.67 M +$8.22 M +565% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $32 M $14.5 M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $11.9 M +$10.7 M +856% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $4.03 M +$2.95 M +271% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $1.46 M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q3 2019 $1.25 M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $1.09 M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.